Tata Consultancy Services Quarterly Results – FY26 Q4 Analysis
Key Highlights / What This Means
The company delivered strong year-over-year growth in both revenue and net profit, supported by expenses growing at a slower rate. This indicates a positive trend in operational performance and profitability.
Quarterly Analysis
- Revenue increased to ₹70,698 Crores (+9.65% YoY, +5.38% QoQ), indicating strong top-line growth.
- Net Profit rose to ₹13,784 Crores (+12.1% YoY, +28.6% QoQ), showing robust bottom-line expansion.
- Expenses grew 8.12% year-over-year to ₹53,093 Crores, at a slower pace than revenue growth.
- Employee Benefit Expense increased by 9.2% year-over-year to ₹40,143 Crores, reflecting rising operational costs.
- Other Income decreased by 26.4% year-over-year to ₹757 Crores, impacting overall income.
Tata Consultancy Services Ltd. reported solid financial results for the fourth quarter of FY26. Revenue demonstrated consistent year-over-year growth, reaching ₹70,698 Crores, an increase of 9.65% compared to the same quarter last year. This top-line expansion was also evident on a sequential basis, with revenue growing by 5.38% from the previous quarter.
Profitability metrics showed strong year-over-year performance. Net Profit for the quarter was ₹13,784 Crores, a 12.1% increase compared to the prior year's comparable quarter. This bottom-line growth occurred while total expenses grew at a slightly slower pace of 8.12% year-over-year, reaching ₹53,093 Crores. Employee Benefit Expense, a significant cost component, increased by 9.2% year-over-year to ₹40,143 Crores.
While overall profitability improved year-over-year, Other Income experienced a notable decrease. Other Income was ₹757 Crores, a reduction of 26.4% compared to the same quarter last year. This decline in Other Income contrasted with the absence of exceptional charges this quarter, unlike the significant charge recorded in the previous quarter.
Technical Details
The quarter was dominated by a distribution phase, characterized by a downtrend and weak structure. Despite oversold momentum signals, price action near range support and increasing volume suggest persistent selling pressure without immediate signs of reversal.
The price journey began at 3215.0 and concluded at 2358.9, marking a significant decline of 26.63% for the quarter. The closing price settled at the very bottom of the quarterly range, just 1% above the low, indicating a weak finish.
Early in the quarter, price action likely reflected the prevailing downtrend. While specific mid-quarter shifts are not detailed, the overall trajectory and the dominant distribution phase suggest a pattern of attempts to rally that ultimately failed, leading to further declines. The latter part of the quarter saw the price testing the lower bounds of its range.
The trend regime remained firmly in a downtrend across short, medium, and long terms, with an overall downtrend. This was supported by a weak structure, evidenced by a low percentage of higher highs and higher lows, and price consistently trading below key moving averages (SMA20 and SMA50). The downward slope of the SMA50 further reinforces the bearish technical picture.
Volume behavior showed an increasing trend, which, in the context of declining prices, suggests growing participation from sellers and confirms distribution dynamics rather than providing support for any upward moves. Volatility remained in a normal regime, though its trend was falling, indicating that while price moves were significant, the overall risk conditions were not expanding dramatically.
The dominant phase is clearly distribution, driven by the persistent downtrend, weak structure, and the interpretation of increasing volume during price declines. The lack of conviction in price action, as indicated by the price's position near range support and the muted event reaction, supports this phase.
A key event observed during the quarter was elevated volatility, which is consistent with a distribution phase where price swings can be sharp as selling pressure is absorbed or distributed.